The MAHA movement was built on anti-vaccine activism, but its summit ahead of the midterms dropped vaccines entirely and turned into a sponsor showcase, with top slots going for $300,000.
MAHA, the Make America Healthy Again movement, has always had two faces. Its leadership includes committed anti-vaccine activists, and it also tells you to eat more vegetables and get enough sleep — sound advice, hard to take from people who get nostalgic about measles.
The people who paid got the stage
At last week's summit in a Washington hotel ballroom, Vice President Vance and Medicaid chief Oz turned up to lend polish. But most of the day belonged to sponsors.
A Walmart executive talked about making food labels simpler and more transparent, without saying how. A cancer-screening company had just won a favorable FDA panel vote. Two wellness firms stand to profit if the FDA lets gray-market peptides be made and prescribed.
Bloomberg reported that companies paying $300,000 got what it called meaningful input on panelists and topics.
Vaccines quietly left the room
Del Bigtree, once Kennedy's communications director, spent the day chatting with fans. His verdict: this probably should be called the MAHA Food Summit.
Kennedy himself has never broken with them. Two weeks ago he told his own anti-vaccine group they had a steadfast friend in the White House. On Monday he previewed plans to use a database of Americans' health records to compare autism rates among the vaccinated and unvaccinated — even though research has found no such link.
The room also held people who came for something else: psychedelics for depression, AI for health care, answers their doctors could not give. Not necessarily Kennedy fans.
The midterms will test how far that banner stretches.
Why it matters
A movement's real platform is not what gets said on stage but who paid and what they got for it. With the anti-vaccine veterans relegated to the hallway and peptide companies buying the agenda, MAHA has shifted from an ideological cause into an access channel for supplement and screening businesses.
Curated from high-quality sources, with concise summaries and key takeaways.
